A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer
Clinical trial NCT05634499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05634499
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2026-08-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.